Recent Updates — BKHA

Black Hawk Acquisition Corp entered into financing agreements with Meteora Select Trading Opportunities Master LP to support its business combination with Vesicor Therapeutics. The transaction includes a Forward Purchase Agreement for up to 1,350,000 shares at an initial reset price of $10.00 per share and a Non-Redemption Agreement where Meteora agreed not to redeem up to 2,124,077 shares. Additionally, the parties executed a Standby Equity Purchase Agreement (SEPA) allowing PubCo to sell up to $200 million in common stock over 36 months at 97% of market price, along with Registration Rights Agreements for resale. Black Hawk Acquisition Corp operates as a blank check company focused on merging with Vesicor Therapeutics, Inc., a biotechnology firm.

Black Hawk Acquisition Corp deposited $150,000 into its trust account to extend the deadline for consummating an initial business combination by one month, moving from September 22, 2026, to October 22, 2026. This special purpose acquisition company operates in the financial services industry, focusing on identifying and merging with private companies.

Black Hawk Acquisition Corp issued a convertible promissory note to its Sponsor, Black Hawk Management LLC, with a principal amount of up to $300,000. The note bears interest at 10% per annum starting July 8, 2026, and matures upon the closing of an initial business combination or liquidation. Upon conversion in a DeSPAC transaction, the note converts into common stock at $1.00 per share. This SPAC is seeking to identify and merge with a target company.

Black Hawk Acquisition Corporation deposited $150,000 into its trust account to extend the deadline for consummating an initial business combination by one month. The extension moves the date from August 22, 2026, to September 22, 2026. This SPAC operates in the financial services industry, specifically as a blank check company focused on identifying and merging with private entities.